Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398489
Status:
UNKNOWN
Last Update Posted:
2010-11-09
First Post:
2006-11-09
Brief Title:
Docetaxel Epirubicin and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Sponsor:
Technical University of Munich
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000516034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Technical University of Munich
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None